chr11-108329071-AAATGGAAAAAT-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.7141_7151delAATGGAAAAAT(p.Asn2381GlufsTer18) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.7141_7151delAATGGAAAAAT | p.Asn2381GlufsTer18 | frameshift_variant | Exon 49 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:2
Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant has been observed in individual(s) with ataxia-telangiectasia (PMID: 26628246). ClinVar contains an entry for this variant (Variation ID: 555855). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asn2381Glufs*18) in the ATM gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. -
- -
Hereditary cancer-predisposing syndrome Pathogenic:2
This variant deletes 11 nucleotides in exon 49 of the ATM gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of ATM function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
The c.7141_7151del11 pathogenic mutation, located in coding exon 48 of the ATM gene, results from a deletion of 11 nucleotides at nucleotide positions 7141 to 7151, causing a translational frameshift with a predicted alternate stop codon (p.N2381Efs*18). This alteration has been reported in a patient affected with ataxia telangiectasia, confirmed in trans with ATM c.8911C>T (p.Gln2971X) (Liu XL et al. Neurosci Lett, 2016 Jan;611:112-5). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Breast and/or ovarian cancer Pathogenic:1
- -
Familial cancer of breast Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at